Fibrinolysis syndrome
{{Infobox medical condition (new)
| name =
| synonym = Defibrinating syndrome
| image =
| image_size =
| alt =
| caption =
| pronounce =
| specialty =
| symptoms =
| complications =
| onset =
| duration =
| types =
| causes =
| risks =
| diagnosis =
| differential =
| prevention =
| treatment =
| medication =
| prognosis =
| frequency =
| deaths =
}}
Fibrinolysis syndrome is characterized by an acute hemorrhagic state brought about by inability of the blood to clot, with massive hemorrhages into the skin producing blackish, purplish swellings and sloughing.{{cite book |author1=James, William D. |author2=Berger, Timothy G. |title=Andrews' Diseases of the Skin: clinical Dermatology |publisher=Saunders Elsevier |year=2006 |isbn=978-0-7216-2921-6 |display-authors=etal}}{{rp|826}}
Symptoms
Hemorrhages (this includes severe bleeding of any particular area. Be it: nasal, rectal, oral, it also includes bleeding from scrapes, cuts, bruises (big bruises that do not disappear in the first two to three days).
Cause
The cause for Fibrinolysis syndrome, is the inability of the body to produce blood-coagulates to stop bleeding. What causes the body to not produce blood-coagulates are the low levels of fibrin, or therefore non-existent fibrin.{{cite journal|last=Merskey|first=C.|author2=Johnson, A. J.|author3=Kleiner, G. J.|author4=Wom, H.|title=The Defibrination Syndrome: Clinical Features and Laboratory Diagnosis|journal=Department of Medicine and the American National Red Cross Research Laboratory|volume=13|year=1967|issue=4 |pages=528–549 |doi=10.1111/j.1365-2141.1967.tb00762.x|pmid=6029954 |s2cid=20990370 }} Fibrin is a non-globular protein involved in the clotting of blood.
Diagnosis
{{Empty section|date=September 2017}}
Treatment
{{Empty section|date=September 2017}}
See also
References
{{reflist}}
{{Cutaneous vasculitis}}
Category:Vascular-related cutaneous conditions
{{Cutaneous-condition-stub}}